Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).
Petricoul O, Nazarian A, Schuehly U, Schramm U, David OJ, Laurent D, Praestgaard J, Roubenoff R, Papanicolaou DA, Rooks D.
Petricoul O, et al. Among authors: schuehly u.
Clin Pharmacokinet. 2023 Jan;62(1):141-155. doi: 10.1007/s40262-022-01189-0. Epub 2022 Dec 17.
Clin Pharmacokinet. 2023.
PMID: 36527600
Clinical Trial.